Target intelligence / Profile preview

Elongation factor 1-alpha (EF-1α) (EF-1α)

Target
EF-1α
Molecular classification
Enzyme, Translation factor, GTPase
01

Overview

Elongation factor 1-alpha (EF-1α), frequently referred to as P74 in the context of Leishmania vaccine research, is a highly conserved protein essential for the parasite's protein synthesis machinery. It functions as a GTPase that facilitates the delivery of aminoacyl-tRNAs to the ribosome during the elongation phase of translation. Beyond its housekeeping role, Leishmania EF-1α acts as a potent virulence factor that is secreted into the host macrophage environment. Once inside the host cell, it interacts with and activates the host protein tyrosine phosphatase SHP-1, which suppresses microbicidal activities such as nitric oxide production and pro-inflammatory cytokine signaling. Due to its essentiality and strong immunogenicity, P74 is a primary component of the LEISHDNAVAX DNA vaccine candidate, which aims to induce a protective Th1-type immune response. The high sequence identity between the parasite and human versions of this protein poses a challenge for the development of selective small-molecule inhibitors, but its unique role in host-parasite interactions makes it a significant target for both prophylactic and therapeutic strategies against leishmaniasis.

Other names
P74LdP74Leishmania P74EF1ATranslation elongation factor 1-alphaLeIF
02

Mechanism of action

Induction of Th1-type cellular immune response and activation of CD4+ and CD8+ T cells.

03

Biological functions

Protein synthesisTranslationGTP bindingImmune evasionHost cell modulationActivation of host SHP-1
04

Disease associations

InfectionLeishmaniasisVisceral leishmaniasisCutaneous leishmaniasisMucocutaneous leishmaniasis
05

Safety considerations

High sequence homology with human elongation factor 1-alphaPotential for autoimmune cross-reactivityTherapeutic delivery challenges for intracellular targeting
06

Interacting drugs

LEISHDNAVAX
07

Biomarkers

Interferon-gamma (IFN-γ)Interleukin-2 (IL-2)Parasite load in spleen and liver

Beyond the preview

Go deeper on Elongation factor 1-alpha (EF-1α) (EF-1α).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor 1-alpha (EF-1α) (EF-1α).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call